ACRO’s new RBQM Summary Report highlights the key takeaways from ACRO’s RBQM survey, outlining the current state of RBM & RBQM in the clinical research industry.
ACRO’s RBQM Working Group published data from the third annual
landscape survey on how RBM & RBQM is being utilized in clinical trials.
Created collaboratively by committee members, the Principles Statement is comprised of four key principles and associated actions that are vital to the work of ensuring all trials are diverse, inclusive, and equitable.
Get ACRO’s newsletter to stay informed about our work and the industry.
While large pharmaceutical companies frequently turn to functional service providers for #ClinicalTrial work, these partnerships can benefit teams of any size. @SyneosHealth explores solutions and resources for small- and mid-sized groups. https://bit.ly/44XTluL
Patient #ClinicalTrial participation should be straightforward and smooth. eCOAs, or Electronic Clinical Outcome Assessments, can be a faster, more accurate, and more cost-effective way to support accessibility. Read more from @Clario: https://bit.ly/3Rtl43l
An effective #biopharma media campaign includes measurement frameworks, audience segmentation, channel identification, and more. @veevasystems details the best practices to follow to improve performance during these crucial efforts. https://bit.ly/3PjqQBQ
Best Practices for 2024 Biopharma Campaign Success | Veeva
These measurement and activation best practices can optimize audience segments for improved campaign performance.
bit.ly
There have been tremendous shifts made across the #ClinicalTrial monitoring landscape in recent years. @FlorenceHCare lays out the various options available today, from in-person to remote monitoring. Get the rundown here: https://bit.ly/3oNlYM6
WASHINGTON, DC – Washington DC – ACRO is pleased to announce that its Board of Directors has elected Paul Kirchgraber, M.D., Executive…
WASHINGTON, DC – Today, the Association of Clinical Research Organizations (ACRO)’s DCT Working Party releases the latest addition to its DCT Toolkit:…
Our member companies have faced widespread clinical trial disruptions in the past few years – from the global pandemic, to the war…
WASHINGTON, DC – This week, the Association of Clinical Research Organizations (ACRO)’s Diversity and Inclusion in Clinical Trials committee is proud to…
The below is an Op-Ed authored by ACRO Chair, Jackie Kent, for MedPage Today on August 6, 2022. Read the full article…
With bipartisan sponsorship from Representatives Pallone (D-NJ) and McMorris Rodgers (R-WA) the American Data Privacy and Protection Act (ADPPA), which would create…
Half of all clinical trials occur in the US. ACRO works with US legislators and regulators to ensure a positive regulatory environment that supports high-quality, safe and ethical clinical research. More »
ACRO engages with European regulators, connecting its members with critical stakeholders. We support the clinical research industry and provide CRO expertise. More »
ACRO’s CRO Forum is a formal mechanism to enable clinical research organizations to interact with TransCelerate BioPharma Inc. on a range of issues that impact the industry. More »
In Europe and the US, ACRO gathers government leaders and key stakeholders to inform, educate and promote the unique contributions of clinical research and technology companies. More »
ACRO’s Global Data Protection & Privacy Committee advances issues of data privacy, protection and security, and how the industry interprets policies and prepares for upcoming legislation. More »
We help create a global regulatory and business environment
where ACRO members succeed
; 
